As many as 7 million new enrollees could sign up for health insurance during the Affordable Care Act’s second open enrollment cycle which begins November 15, according to the Congressional Budget Office (CBO).
As many as 7 million new enrollees could sign up for health insurance during the Affordable Care Act’s second open enrollment cycle which begins November 15, according to the Congressional Budget Office (CBO).
Last year 8 million individuals signed up during the first open enrollment cycle, and 7.3 million paid their premiums. The CBO predicts that there may be as many as 25 million new enrollees through the federal marketplace by 2017.
Sylvia Burwell, secretary of the U.S. Department of Health and Human Services (HHS), has been in office for four months and during that time she’s overseen a major effort to fix the problems experienced last year when the healthcare.gov website went live. Burwell has brought in new management and industry IT pros to streamline the system and subject it to testing by outside firms, alpha testing with plan issuers, and end-to-end testing of the whole system.
The aim is to make the healthcare.gov website more consumer friendly so that enrollment will be faster and easier. Most new customers will face only 16 screens when completing a basic application versus 76 from the last enrollment cycle, and they’ll be able to shop on a limited basis for insurance before signing up. HHS officials say the system can handle at least 125,000 simultaneous users. But searching for specific providers in plans does not yet work.
Attracting new enrollees might be a challenge, though. Many of the initial participants had pre-existing conditions or sufficiently low income to qualify for subsidies and were eager to sign up. Now it might be more difficult to bring in those who sat out last year’s sign-up period. But the program’s success has attracted more insurers, with HHS anticipating a 25% increase in firms offering coverage through the federal marketplace this year. The increased competition could limit premium hikes, but the range of options and rates will vary greatly from state to state.
An important issue for industry is whether the improved system will be able to transfer enrollment information to insurers, a shortcoming that took months to fix. Work on the program’s back-end may not be finished until early next year, creating uncertainty about just when plans will be able to obtain updated data on beneficiary income and appropriate subsidies.
To reach even unofficial enrollment goals, the program needs to retain those who signed up during the initial open enrollment cycle, which ran through March 2014. Insurers have sent out renewal notices with 2015 premium information, and returning plan members who take no action will be automatically renewed as of January 1.
However, it’s not clear what beneficiaries should do if a plan has changed or is no longer the best deal for the individual in terms of costs, provider networks and drug coverage. HHS is encouraging enrollees to revisit the marketplace to make sure their personal information is correct so they get the right subsidy. But accessing current coverage information requires a 14-digit identity code, which many consumers may not know. Returning users will not be able to use the revised application process to make changes in coverage. And some 6 million beneficiaries with subsidized coverage may not realize there are changes.
An added problem for insurers is that current beneficiaries have until February 15 to change coverage, which means it will be uncertain just who is staying in a plan until the end of the sign-up period.
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More